These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10468958)

  • 21. bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer.
    Popescu RA; Lohri A; de Kant E; Thiede C; Reuter J; Herrmann R; Rochlitz CF
    Eur J Cancer; 1998 Jul; 34(8):1268-73. PubMed ID: 9849490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of apoptosis and cell cycle related genes in proliferating and colcemid arrested cells of divergent lineage.
    Gallaher BW; Berthold A; Klammt J; Knüpfer M; Kratzsch J; Bartsch M; Kiess W
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):79-88. PubMed ID: 10726974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of c-Myc activity and apoptosis in vivo.
    Alarcon RM; Rupnow BA; Graeber TG; Knox SJ; Giaccia AJ
    Cancer Res; 1996 Oct; 56(19):4315-9. PubMed ID: 8813114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
    Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
    J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Sochalska M; Schuler F; Weiss JG; Prchal-Murphy M; Sexl V; Villunger A
    Oncogene; 2017 Apr; 36(15):2066-2073. PubMed ID: 27694901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenes and cell death.
    Harrington EA; Fanidi A; Evan GI
    Curr Opin Genet Dev; 1994 Feb; 4(1):120-9. PubMed ID: 8193531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
    Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNs.
    Li R; Cheng Y; Gao C
    Bull Cancer; 2006 Nov; 93(11):E119-25. PubMed ID: 17145575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
    Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
    de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
    Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
    Eliopoulos AG; Kerr DJ; Herod J; Hodgkins L; Krajewski S; Reed JC; Young LS
    Oncogene; 1995 Oct; 11(7):1217-28. PubMed ID: 7478541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of neuroendocrine tumours models assessed by kinomic profiling.
    Romano D
    Ann Endocrinol (Paris); 2019 Jun; 80(3):144-148. PubMed ID: 31054767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of apoptosis-suppressing gene bcl-2 in human carotid body tumours.
    Wang DG; Johnston CF; Barros D'Sa AA; Buchanan KD
    J Pathol; 1997 Oct; 183(2):218-21. PubMed ID: 9390036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
    Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
    J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.